(Press-News.org) Researchers at University of California San Diego School of Medicine and their colleagues have developed the first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime.
The team quantified the gene expression of more than 58,000 individual hematopoietic (blood) stem cells at seven stages, from early fetal development to old age. They documented consistent changes in the types of blood cells that are produced in response to the functional demands of each life stage:
The early prenatal period is characterized by myeloid cell production after conception: tissue-resident macrophages, immune cells that play a crucial role in supporting early organ development, followed by rapid growth in the second trimester which requires the production of red blood cells for robust oxygen delivery throughout the fetus.
At birth, there is a shift to lymphoid cells. These white blood cells play an important role in establishing lifelong immunity following the sudden exposure to the outside environment and its pathogens. Lymphoid cells remain dominant through childhood.
In adulthood, lymphoid cell production wanes, but myeloid cell production expands again over time.
The researchers also found that changes in blood cell types across the lifetime can have important implications for blood cancers. They classified acute myeloid leukemia cells by their resemblance to gene expression of stem cells at different life stages, discovering that the normal stem cell age most reflective of leukemia cells in patients with acute myeloid leukemia can vary widely, regardless of a patient's age.
What’s more, patients whose leukemia cells more closely reflected young blood cell production had a much worse prognosis than those whose leukemia cells more closely reflected old blood cell production. The researchers believe the cancer cells may reprogram themselves to have fetal attributes that make them more aggressive. Further investigation identified seven transcription factor genes that strongly influence whether leukemia cells looked like old or young blood cells.
Future studies are planned to test whether the disease takes advantage of the highly proliferative capacity of young blood cells to make patients’ leukemia more deadly than older, less vigorous blood cells. They are also hopeful that leukemia cells could eventually be reprogrammed.
“If we can develop drugs that target key factors that drive young blood cell production, maybe the leukemia will just reflect old blood cell production and be easier to treat,” said Hojun Li, M.D., Ph.D., an assistant professor of pediatrics at UC San Diego School of Medicine, UC San Diego Moores Cancer Center member and an attending physician at Rady Children's Hospital-San Diego, who led the study along with R. Grant Rowe, M.D., Ph.D., an assistant professor of pediatrics at Boston Children's Hospital, Harvard Medical School.
The study was published on December 5 in Nature Methods.
# # #
END
Research alert: Changes in blood cell production over the lifetime could impact leukemia outcomes
2024-12-05
ELSE PRESS RELEASES FROM THIS DATE:
Controlling cancer cells’ gluttony for glutamine
2024-12-05
Cancer cells are like booming cities without urban planners. They expand quickly, and in doing so, the resulting tumors consume more energy and other resources than they can acquire from nearby blood vessels.
Rather than limiting their growth to more sustainable rates, cancer cells adapt by finding alternative ways to scavenge what they need. One scrounging strategy prevalent in pancreatic ductal adenocarcinoma (PDAC) involves cancer cells reshaping their cell surfaces to snatch extra nutrients from the jelly-like substance between cells or extracellular ...
NASA’s Hubble takes the closest-ever look at a quasar
2024-12-05
Astronomers have used the unique capabilities of NASA's Hubble Space Telescope to peer closer than ever into the throat of an energetic monster black hole powering a quasar. A quasar is a galactic center that glows brightly as the black hole consumes material in its immediate surroundings.
The new Hubble views of the environment around the quasar show a lot of "weird things," according to Bin Ren of the Côte d'Azur Observatory and Université Côte d'Azur in Nice, France. "We've got a few blobs of different sizes, and a mysterious L-shaped filamentary structure. This is all within 16,000 light-years of the black hole."
Some ...
BeginNGS® newborn screening by genome sequencing shown to be safe and effective in two clinical studies
2024-12-05
San Diego – Dec. 5, 2024 – Two studies published today in the American Journal of Human Genetics show the potential for genomic screening in newborns to address high rates of infant hospitalization and mortality in the United States. Presently, hundreds of genetic diseases are either preventable or treatable but currently are detected only after a child falls ill and endures a years-long “diagnostic odyssey,” often receiving diagnoses too late to achieve the best outcomes.
The first study, titled “Prequalification of genome-based newborn screening for severe childhood genetic diseases ...
Scientists discover new receptor for nerve growth factor—a promising target for treating pain
2024-12-05
Researchers at the NYU Pain Research Center have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a study published in the Journal of Clinical Investigation. The findings hold promise for finding new treatments for arthritis and other forms of inflammatory and cancer pain, without the side effects that led recent therapies to fail in clinical trials.
“Nerve growth factor is unusual because it’s one of the few patient-validated targets for pain,” said Nigel Bunnett, professor and chair of the Department of Molecular Pathobiology ...
New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
2024-12-05
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine in St. Louis. The trial showed that patients being treated for various blood cancers tolerated the investigational drug — called itacitinib —and experienced lower-than-expected rates of graft-versus-host disease (GvHD), in which the donor’s stem cells attack the patient’s healthy tissues.
The study is online in the journal Blood.
“We have to be cautious about interpreting the results of a small ...
IGB researchers leverage team science to develop InSTAnT Toolkit
2024-12-05
In a new study published in Nature Communications, a team of researchers at the Carl R. Woese Institute for Genomic Biology report a new, robust computational toolset to extract biological relationships from large transcriptomics datasets. These efforts will help scientists better investigate cellular processes.
Living organisms are governed by their genome—an instruction manual written in the language of DNA that dictates how an organism grows, survives, and reproduces. By regulating the abundance of different RNA transcripts, cells control their protein expression level, thereby shaping their functions ...
AADOCR elects new Vice-president, Treasurer, and Representative to the IADR/AADOCR Publications Committee
2024-12-05
Alexandria, VA – Members of the American Association for Dental, Oral, and Craniofacial Research (AADOCR) have elected Margherita R. Fontana, University of Michigan, Ann Arbor, as Vice-president, Julie Frantsve-Hawley, Temple University Kornberg School of Dentistry, Philadelphia, PA, as Treasurer, and Ariadne Letra, University of Pittsburgh School of Dental Medicine, PA, as Representative to the IADR/AADOCR Publications Committee. Their terms will commence at the conclusion of the 54th Annual Meeting ...
IADR elects Raul Garcia as Vice-president
2024-12-05
Alexandria, VA, USA – Members of the International Association for Dental, Oral, and Craniofacial Research (IADR) have elected Raul I. Garcia, Boston University, USA, to serve as Vice-president. His term will commence at the conclusion of the 103rd General Session of the IADR, which will be held in conjunction with the 2025 IADR Pan European Regional Congress from June 25-28, 2025 in Barcelona, Spain.
Garcia is Professor and Chair of the Department of Health Policy and Health Services Research at the Henry M. Goldman School of Dental Medicine at Boston University. He received his DMD and MMedSc from the Harvard ...
Seven researchers named to Battelle Distinguished Inventor cadre
2024-12-05
Seven scientists affiliated with the Department of Energy’s Oak Ridge National Laboratory have been named Battelle Distinguished Inventors in recognition of being granted 14 or more United States patents. Since Battelle began managing ORNL in 2000, 104 ORNL researchers have reached this milestone.
“These innovators have not only developed cutting-edge technologies, but they have also prioritized taking the steps to move them out into the marketplace, which is critical for adoption and broad impact,” said Susan Hubbard, ORNL deputy for science and technology. “The innovators are working on a range of strategies important for our ...
Gene therapy fixes major cause of stillbirth, premature birth in guinea pig model
2024-12-05
The life of billions of people inhabiting Earth is owed to a temporary organ that supported and nourished them in a mother’s womb.
The placenta, or afterbirth, is considered sacred by some cultures, its pivotal role in pregnancy recognized as far back as the raising of Egypt’s pyramids. It provides nutrients and oxygen to the fetus via the umbilical cord, acting like a gut, kidney, liver, and lungs.
If the placenta fails, only one hazardous option remains — premature delivery through induced labor or cesarean delivery.
Now, the first therapy to potentially ...